LWM
BMY.RT

Lenox Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Lenox Wealth Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$0 Hold
49
– – ﹤0.01% 822
2020
Q1 		$0 Hold
49
– – ﹤0.01% 790
2019
Q4 		$0 Buy
+49
New +$127 ﹤0.01% 752

Other funds holding BMY.RT

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lenox Wealth Management's BMY.RT Position: Q2 2020 in Review

Lenox Wealth Management held its Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) position steady in Q2 2020 at 49 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #822.

Lenox Wealth Management first reported a position in BMY.RT in Q4 2019 and has held it in 3 quarters since. 583 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2020.

  • Lenox Wealth Management held 49 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $0 as of Q2 2020.
  • Lenox Wealth Management left its Bristol-Myers Squibb Company Contingent Value Rights share count unchanged in Q2 2020.
  • Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #822 holding.
  • Lenox Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and has held it in 3 quarters since.
  • 583 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.